NMD4C Host Inaugural Basic Research Summer School
Over May 27-28 2024, the NMD4C animal and cell-based research team hosted the first-ever annual basic research summer school for neuromuscular research trainees at McGill University in Montréal, QC.
We were pleased to welcome 36 trainees at the MSc, PhD, and postdoctoral level, alongside patient partners, senior scientists and members of industry for a packed program over two full days. Trainees presented flash talks on their research interests, received lectures from patient partners, senior scientists and industry members before participating in hands-on workshops in the afternoon. Each evening, the attendees also had the chance to attend networking events and ask questions to a panel on the topic of “Careers in NMD research”.
Dr Benoit Gentil leads a cohort of summer school attendees through a cell modelling workshop.
Alessio Cusmano (Chang lab) demonstrates techniques in muscle satellite stem cell isolation from mouse models.
Panel discussion with senior investigators and industry member on day 2 of summer school.
Thank you to all attendees at the first NMD4C summer school!
The diverse sessions offered opportunities for attendees to receive training in cutting-edge wet lab and bioinformatics techniques, while providing an environment to network in-person with colleagues and senior investigators from across Canada, broadening their academic network and fostering future collaborations.
We hope to see you next year
We are also excited to announce that we will host this event again next summer, with details on the event location, organizing team and registration to come! Stay tuned to our event webpage for the latest updates.
Thank you to the Organizing team
Lastly, we would like to extend a special thank-you to our organizing team – without their tireless work behind the scenes, this event would not have been possible. Thank you to Dr Natasha Chang, Dr Kessen Patten, Dr Marine Christin, Alessio Cusmano, Dr Nicolas Dumont, Dr Benoit Gentil, Dr Rashmi Kothary, Dr Léa Lescouzères, Dr Homira Osman, Dr Martine Tétreault, Dr Erin Beattie and James Davis.
Thank you to our sponsors
Thank you to the institutions and organizations who provided support for this event: McGill Faculty of Medicine and Health Sciences, McGill School of Biomedical Sciences, The Stem Cell Network, ThéCell, and Amazon Web Services.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.